Inaktiver Wert

Andere Sprachen Novo Nordisk A/S SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT

Aktien

NOVOB

DK0060102614

NOVOB

Schlusskurs SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT Andere Börsenplätze
- ^DKK	-

28.06.	Indien plant Anreize für Hersteller von Diabetes- und Adipositas-Medikamenten bis 2026, so ein Regierungsbeamter	RE
28.06.	UBS hebt Ziel für Novo Nordisk auf 1100 Kronen - 'Neutral'	DP

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ETF van de week: beleggen in Europa zonder Frankrijk om politiek risico te omzeilen	28.06.
India plans incentives for diabetes, obesity drug makers in 2026, government official says	28.06.
European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk	27.06.
Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot	27.06.
ETF de la semana: Invertir en Europa fuera de Francia para evitar el riesgo político	27.06.
L'ETF della settimana: investire in Europa escludendo la Francia per evitare il rischio politico	27.06.
Novo Nordisk to Limit Launch of Wegovy in China, Executive Says	27.06.
Toujours les mêmes qui gagnent	27.06.
The same old winners	27.06.
En Direct des Marchés : Euroapi et OVH s'exposent, Novo Nordisk se rate, Micron déprime	27.06.
Borsa di Italia: I soliti vincitori	27.06.
Bolsa de Madrid: Los mismos ganadores de siempre	27.06.
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	26.06.
2seventy Bio Sells Gene Editing Therapy To Novo Nordisk for Up To $40 Million	26.06.
Sector Update: Health Care Stocks Softer Late Afternoon	26.06.
Sector Update: Health Care Stocks Lower in Afternoon Trading	26.06.
Sector Update: Health Care	26.06.
European Equities Close Lower in Wednesday Trading	26.06.
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	26.06.
Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial	26.06.